Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
about
Epidemiology of Japanese encephalitis: past, present, and future prospectsEmergence or improved detection of Japanese encephalitis virus in the Himalayan highlands?Japanese encephalitis: Challenges and intervention opportunities in Nepal.Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults.Climate Change and Spatiotemporal Distributions of Vector-Borne Diseases in Nepal--A Systematic Synthesis of Literature.Control of Japanese encephalitis in Asia: the time is nowAetiologies of central nervous system infections in adults in Kathmandu, Nepal: a prospective hospital-based study.Adapting Nepal's polio eradication programmePotential chemotherapeutic targets for Japanese encephalitis: current status of antiviral drug development and future challenges.Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies.Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children.Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.Spatio-temporal epidemiology of Japanese encephalitis in Nepal, 2007-2015.Updated estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal.Immunogenicity of a live-attenuated Japanese encephalitis vaccine in children and adolescents after hematopoietic stem cell transplantation.
P2860
Q27023948-77F2F308-87B6-4129-92B6-C6D7D9FF5ABBQ31054946-57CC648B-C7C8-409D-9C32-38112BAE193CQ31068975-7A79F255-5C01-4F01-B629-EB5B852A2A2FQ33692361-5C631C0A-3053-4F8B-93FE-562C7224B957Q35667358-F1FD28C5-38E6-415A-9908-055D6CD94337Q36125852-0057C8D3-0CAE-4BB1-B4C0-C1ADCA99E16FQ37080276-1455D001-C2CD-47B9-A922-10DB4ABC0A89Q37669316-C03CDEA1-2155-4E92-BFE3-7708EDFD6A2AQ38544126-318C38FB-E0DD-4EFE-9FED-513B401991BCQ38608325-A1067DC8-6C77-42B9-B9DD-FB639378B723Q38640233-D2F8632C-3D1E-47F0-A5AF-41F77B8F2B25Q39181962-61BC7ABE-EE0A-4F23-9B9B-BCF089C31AFBQ40107547-155D3045-4A57-4344-8200-29C4EAF5E140Q42362024-81C837AD-C6EF-4327-A014-C7A104A3D717Q51125991-9E23C3DA-C01B-4423-B989-79D14A053FEA
P2860
Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@ast
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@en
type
label
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@ast
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@en
prefLabel
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@ast
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@en
P2093
P2860
P50
P921
P356
P1476
Estimation of the impact of a ...... ed SA 14-14-2 vaccine in Nepal
@en
P2093
Geeta Shakya
Kristen B Janusz
Murari Man Shrestha
Ram Padarath Bichha
Robert V Gibbons
Sanjaya K Shrestha
Shyam Raj Upreti
Tika Ram Sedai
W William Schluter
P2860
P304
P356
10.4269/AJTMH.12-0196
P407
P577
2013-01-28T00:00:00Z